Dental Bone Grafts and Substitutes Market Size & Growth Forecast 2027–2036, By Segments (End-use, Material Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Dental Bone Grafts and Substitutes Market size was around USD 973.1 million in 2026 and is slated to grow at a 8.65% CAGR from 2027 to 2036, crossing USD 2.23 billion by 2036. The industry revenue for 2027 is estimated at USD 1.04 billion.

• Base Year Value (2026): USD 973.1 million
• CAGR (2027-2036): 8.65%
• Forecast Year Value (2036): USD 2.23 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Dental Bone Grafts And Substitutes Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America captured a 40.28% share in 2026 due to high implant procedure volumes, broad availability of advanced biomaterials, and established specialist dental networks supporting routine graft use.
  • Asia Pacific is expected to expand at a 10.74% CAGR, driven by improving access to dental care, growing implant adoption, and wider availability of graft substitutes in urban dental centers.

• Segment Momentum:

  • Dental clinics held a 73.25% share in 2026 because they perform most implant dentistry, periodontal grafting, and socket preservation procedures within specialized treatment workflows.
  • Synthetic graft materials are expanding fastest as clinicians increasingly value standardized composition, consistent manufacturing quality, and reliable performance across a wider range of dental grafting procedures.

• Market Expansion Drivers:

  • Rising volume of dental implant procedures driving demand for bone regeneration materials.
  • Growing geriatric population increasing incidence of periodontal disease and tooth loss.
  • Expanding dental tourism and lower-cost implant procedures boosting graft material adoption.

• Leading Market Participants:

  Prominent players in the dental bone grafts and substitutes market include Geistlich Pharma AG (Switzerland), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (USA), Dentsply Sirona Inc. (USA), Straumann Holding AG (Switzerland), Stryker Corporation (USA), Baxter International Inc. (USA), Smith & Nephew plc (UK), Envista Holdings Corporation (USA), BioHorizons (USA).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 973.1 million
  • 2027 Estimated Market Size: USD 1.04 billion.
  • Projected Market Size: USD 2.23 billion by 2036
  • Growth Forecasts: 8.65% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Dental Clinics (End-use) | Xenograft (Material Type) | Socket Preservation (Application)
  • Emerging Opportunity Segment: Hospitals (End-use) | Synthetic (Material Type) | Sinus Lift (Application)

Market Growth Drivers and Industry Trends

Rising volume of dental implant procedures driving demand for bone regeneration materials

The increasing use of dental implants is generating greater requirements for materials that can restore or augment insufficient bone structures, thereby driving the dental bone grafts and substitutes market. Implant placement often depends on adequate bone volume and quality, while patients with bone deficiencies may require grafting procedures before or alongside implant treatment. Bone graft materials and substitutes provide clinicians with options for supporting bone regeneration and preparing treatment sites for implant placement. As dental practices expand implant-based restorative care, demand is also increasing for biomaterials that can be selected according to defect characteristics, surgical requirements, and patient treatment plans.

Growing geriatric population increasing incidence of periodontal disease and tooth loss

An expanding older population is contributing to a higher prevalence of oral conditions associated with tooth loss and deterioration of supporting dental structures, supporting the dental bone grafts and substitutes market. Periodontal disease can damage the tissues and bone surrounding teeth, while age-related oral health challenges may increase the need for restorative and implant-based interventions. When tooth loss is accompanied by reduced jawbone volume, grafting materials can be used to support reconstruction and create suitable conditions for subsequent dental procedures. The growing need for comprehensive oral rehabilitation among older patients is therefore increasing the relevance of bone regeneration materials within dental treatment pathways.

Expanding dental tourism and lower-cost implant procedures boosting graft material adoption

The expansion of dental tourism is improving access to implant and restorative procedures in destinations where treatment costs can be comparatively lower, supporting adoption across the dental bone grafts and substitutes market. Patients traveling for dental care may undergo complex implant procedures that require bone augmentation or regeneration as part of the treatment process. The availability of specialized dental clinics and increasing cross-border demand for affordable restorative care can encourage broader use of grafting materials in implant treatment protocols. Dental providers serving these patient populations also require suitable biomaterials to manage different levels of bone deficiency and support implant placement procedures.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising volume of dental implant procedures driving demand for bone regeneration materials	2.30%	High	North America, Europe, Asia Pacific	High	Near Term
Growing geriatric population increasing incidence of periodontal disease and tooth loss	2.10%	High	North America, Europe	High	Near Term
Expanding dental tourism and lower-cost implant procedures boosting graft material adoption	1.90%	Moderate	Asia Pacific, Latin America	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America led the dental bone grafts and substitutes market with a 40.28% share in 2026, underpinned by advanced dental care infrastructure, high adoption of implant-based procedures, and strong demand for restorative and reconstructive treatments. Dental professionals increasingly rely on bone grafting materials to support implant placement and address bone deficiencies associated with tooth loss, trauma, and periodontal conditions. Continued improvements in biomaterials, regenerative techniques, and minimally invasive procedures are expanding clinical applications while supporting more predictable treatment outcomes. A well-established network of dental specialists and greater patient awareness of advanced oral rehabilitation are also contributing to adoption. At the same time, increasing emphasis on aesthetic outcomes and preservation of oral function is encouraging patients and providers to consider regenerative approaches as part of comprehensive dental treatment.

Asia Pacific represents the fastest-growing regional market, supported by expanding dental infrastructure, rising awareness of oral health, and increasing access to advanced restorative procedures. Growing healthcare expenditure and the development of private dental practices are creating new opportunities for implant dentistry and associated bone regeneration technologies. The region's large and increasingly urbanized population is also driving demand for treatments that address tooth loss and restore oral function, while greater awareness of dental aesthetics is supporting elective restorative care. Improvements in clinical training and wider availability of advanced dental materials are helping practitioners adopt modern grafting techniques. Expanding healthcare access, coupled with increasing acceptance of technologically advanced dental procedures, is strengthening the region's potential for sustained market development.

Key Country Insights

United States

Implant Procedure Innovation

The U.S. dental bone grafts and substitutes market is driven by increasing implant procedures and advanced regenerative dentistry. Clinics and manufacturers in the U.S. prioritize biomaterials with proven clinical outcomes, streamlined surgical workflows, and compatibility with digital treatment planning.

Japan

Precision Grafting Solutions

Japan focuses on dental bone grafts that deliver consistent regenerative performance for an aging patient population seeking restorative treatments. Manufacturers in Japan continue refining synthetic and biologic substitutes that integrate efficiently into minimally invasive implant procedures.

South Korea

Digital Implant Integration

South Korea combines advanced implant dentistry with specialized bone graft materials to improve treatment outcomes. Dental providers in South Korea increasingly integrate regenerative products with digital diagnostics and guided surgical techniques for efficient clinical workflows.

Germany

Regenerative Dentistry Focus

Germany emphasizes high-quality dental bone graft materials that support predictable implant success and periodontal reconstruction. Dental professionals in Germany increasingly adopt biomaterials backed by clinical evidence and precision manufacturing standards for complex oral procedures.

France

Clinical Biomaterial Adoption

France expands the use of dental bone graft substitutes across implantology and periodontal therapies requiring reliable tissue regeneration. French dental practices prioritize clinically validated materials that balance handling characteristics with long-term therapeutic performance.

Italy

Restorative Procedure Support

Italy applies dental bone grafts and substitutes across implant restoration and reconstructive oral surgery. Italian clinicians increasingly favor biomaterials that simplify surgical procedures while supporting predictable bone regeneration in routine and advanced cases.

Segment Leadership and Growth Trends

 

End-use Segment Analysis: Dental Clinics (Largest Segment) vs Hospitals (Fastest-Growing Segment)

Dental clinics held the largest share of the dental bone grafts and substitutes market, accounting for 73.25% in 2026. Their dominant position reflects the high concentration of routine and specialized dental procedures requiring bone augmentation and restorative support within dedicated dental care settings. Dental clinics provide focused infrastructure and specialized expertise for procedures involving periodontal, implant-related, and reconstructive treatment. Increasing emphasis on restoring oral function and supporting successful dental interventions continues to sustain demand for grafting and substitute materials in these facilities.

Hospitals represent the fastest-growing end-use segment, supported by the increasing integration of complex dental and maxillofacial procedures within hospital-based care. Hospitals can provide multidisciplinary expertise, advanced surgical infrastructure, and comprehensive support for patients requiring more complex interventions. Greater demand for specialized treatment environments and coordinated care for patients with complicated clinical needs is contributing to the expanding use of dental bone grafts and substitutes in hospitals.

Material Type Segment Analysis: Xenograft (Largest Segment) vs Synthetic (Fastest-Growing Segment)

Xenograft materials dominated the dental bone grafts and substitutes market, representing a 51.09% share in 2026. Their established position is supported by widespread clinical use as bone grafting materials and their ability to provide a scaffold that supports bone regeneration. Xenografts offer clinicians an established material option for managing bone deficiencies associated with dental procedures, particularly where adequate bone volume is needed to support restorative treatment. Continued use of established grafting approaches supports their strong market presence.

Synthetic materials are experiencing the fastest growth, driven by increasing interest in engineered alternatives that can provide controlled and consistent characteristics for bone regeneration procedures. Synthetic grafts can be developed with tailored compositions and physical properties, offering flexibility for different clinical requirements. Ongoing material innovation and increasing interest in alternatives that can address availability, handling, and procedural considerations are supporting greater adoption of synthetic dental bone graft substitutes.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End-use	Hospitals, Dental Clinics	Dental Clinics	Hospitals
Material Type	Autograft, Allograft, Xenograft, Synthetic	Xenograft	Synthetic
Application	Ridge Augmentation, Sinus Lift, Periodontal Defect Regeneration, Implant Bone Regeneration, Socket Preservation	Socket Preservation	Sinus Lift

Competitive Landscape and Market Positioning

Leading companies in the dental bone grafts and substitutes market:

1. Geistlich Pharma AG (Switzerland)

2. Medtronic plc (Ireland)

3. Zimmer Biomet Holdings Inc. (USA)

4. Dentsply Sirona Inc. (USA)

5. Straumann Holding AG (Switzerland)

6. Stryker Corporation (USA)

7. Baxter International Inc. (USA)

8. Smith & Nephew plc (UK)

9. Envista Holdings Corporation (USA)

10. BioHorizons (USA)

The dental bone grafts and substitutes market is advancing with improved biomaterial integration and regenerative dental solutions. Innovations are enhancing compatibility and healing efficiency in clinical procedures. The dental bone grafts and substitutes market continues to grow due to increasing demand for advanced oral reconstruction techniques.

Industry Development/News

Company Name	Date	Key Development
Geistlich	Nov-25	Geistlich introduced Geistlich Bio-Gide Forte, a bone regeneration membrane designed with improved firmness to enhance handling during surgical procedures. The company also announced a flowable version of Geistlich Bio-Oss scheduled for 2026, intended to streamline application in bone regeneration workflows through improved material handling and combined collagen-based formulation characteristics.
LifeNet Health	Feb-26	LifeNet Health developed OraGen, a viable dental bone allograft product composed of cryopreserved corticocancellous bone with demineralized bone matrix and viable cells. The product is designed to enhance osteogenic, osteoconductive, and osteoinductive performance, supporting improved clinical outcomes in dental reconstruction and regenerative bone grafting procedures.
Orthofix Medical Inc.	Oct-23	Orthofix Medical Inc. commercially launched OsteoCove, an advanced bioactive synthetic bone graft available in putty and strip formats. The product expansion enhances the company’s regenerative biomaterials portfolio, supporting broader clinical applications in bone repair procedures and strengthening its competitive positioning in synthetic graft solutions.
BONESUPPORT	Jul-23	BONESUPPORT launched CERAMENT G, a next-generation antibiotic-eluting bone graft substitute featuring enhanced surface sterility. The product strengthens infection-control capabilities in bone regeneration applications and expands the company’s offering in advanced synthetic graft solutions designed for orthopedic and dental reconstructive procedures.
ZimVie Inc.	Apr-23	ZimVie Inc. launched RegenerOss CC Allograft and RegenerOss Bone Graft Plug in North America for dental applications. The introduction expands the company’s regenerative product portfolio and strengthens its positioning in dental bone grafting solutions by broadening clinically usable allograft formats for reconstructive and implant-related procedures.
MTF Biologics	Mar-22	MTF Biologics entered a distribution partnership with Bone Biologics Corporation to commercialize demineralized bone matrix products. The collaboration enhances market access for bone graft materials and strengthens distribution capabilities for biologic graft substitutes across clinical applications in regenerative bone and reconstructive procedures.
Orthofix Medical Inc.	Feb-22	Orthofix Medical Inc. launched Opus BA, a synthetic bioactive bone graft solution designed for cervical and lumbar spine fusion procedures. The product expands the company’s synthetic graft portfolio and strengthens its position in regenerative biomaterials used in spinal and orthopedic reconstruction applications.
AlloSource	Oct-21	AlloSource launched AlloMend Extra-Large (XL) Acellular Dermal Matrix as an extension of its AlloMend product line. The expansion enhances the company’s regenerative tissue portfolio and supports broader clinical use in soft tissue and reconstructive procedures, strengthening its position in biologic graft solutions.
Orthofix Holdings, Inc.	Jul-21	Orthofix Holdings, Inc. launched fiberFUSE Strip, a demineralized fiber bone graft solution incorporating cancellous bone for enhanced regenerative performance. The product introduction expands its bone graft portfolio and supports broader adoption in reconstructive procedures requiring advanced structural and biologic integration.
GreenBone Ortho	Feb-20	GreenBone Ortho received CE Mark approval for its GreenBone Substitute, a naturally derived bone graft material produced from rattan wood. The regulatory clearance enables commercialization in European markets and expands the availability of alternative biomaterial-based graft substitutes for bone regeneration applications.
GRAFTYS	Dec-20	GRAFTYS achieved CE recertification and MDSAP certification across multiple regions, including Brazil, Australia, and the United States, for its sterile calcium phosphate-based bone graft substitutes. These certifications reinforce regulatory compliance and support continued commercialization of its bioresorbable graft portfolio across key international medical device markets.